Imagen de Portada
Código QR

Does high PD-L1 expression reduce the risk of relapse after definitive surgery in patients with oral cavity cancer?

Background: Uncovering the molecular mechanisms of cancer pathogenesis is crucial for improving survival outcomes. Aims: This study investigates the impact of programmed death ligand 1 (PD-L1) expression on the risk of progression in patients with oral squamous cell carcinoma (OSCC). Materials and m...

Descripción completa

Publicado en:Acta Oto-Laryngologica Vol. 145; no. 7; pp. 648 - 654
Autores principales: Babayev, Parvin, Ismayilov, Rashad, Kuscu, Oguz, Akyildiz, Arif, Kurtulan, Olcay, Pamuk, Erim, Guler Tezel, Yesim Gaye, Gullu, Ibrahim Halil
Formato: equations & formulas pictorial research tables/charts Journal Article
Publicado: Taylor & Francis Ltd Jul2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=186450332&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 186450332
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00016489
        B6D
      jtl: Acta Oto-Laryngologica
      issn: 00016489
      maglogo: Y
    pubinfo:
      dt: Jul2025
      vid: 145
      iid: 7
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        186450332
        184668910
        186450332
        186450332
        10.1080/00016489.2025.2489645
        186450332
      ppf: 648
      ppct: 6
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Does high PD-L1 expression reduce the risk of relapse after definitive surgery in patients with oral cavity cancer?
      aug:
        au:
          Babayev, Parvin
          Ismayilov, Rashad
          Kuscu, Oguz
          Akyildiz, Arif
          Kurtulan, Olcay
          Pamuk, Erim
          Guler Tezel, Yesim Gaye
          Gullu, Ibrahim Halil
        affil: Department of Otorhinolaryngology, Hacettepe University Medical School, Ankara, Turkey
      sug:
        subj:
          Programmed Cell Death Ligand 1
          Neoplasm Recurrence, Local Prevention and Control
          Mouth Neoplasms Prognosis
          Carcinoma, Squamous Cell Prognosis
          Mouth Neoplasms Pathology
          Carcinoma, Squamous Cell Pathology
          Gene Expression
          Carcinoma, Squamous Cell Surgery
          Mouth Neoplasms Surgery
          Human
          Male
          Female
          Adult
          Middle Age
          Aged
          Aged, 80 and Over
          Retrospective Design
          Funding Source
          Turkiye
          Cancer Patients
          Immunohistochemistry
          Survival Analysis
          Confidence Intervals
          Descriptive Statistics
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab:
        Background: Uncovering the molecular mechanisms of cancer pathogenesis is crucial for improving survival outcomes. Aims: This study investigates the impact of programmed death ligand 1 (PD-L1) expression on the risk of progression in patients with oral squamous cell carcinoma (OSCC). Materials and methods: The retrospective study included adult patients diagnosed with OSCC between January 2012 and December 2023. PD-L1 expression in tissue removed by definitive surgery was evaluated using immunohistochemistry, and tumor proportion score (TPS) and combined positive score (CPS) were calculated. Survival analyses were performed to assess its prognostic implications. Results: Among the 96 patients, TPS and CPS were 20% or above in 52 (54.2%) and 65 (67.7%) cases, respectively. TPS ≥20% was associated with mucosal lip location, earlier disease stage, and decreased risk of progression. The multivariate Cox regression model revealed that stage III/IV disease (HR: 2.176, 95%CI: 1.085–4.376, p =.029) and TPS ≥20% (HR: 0.241, 95%CI: 0.066–0.879, p =.031) were independent risk factors for progression-free survival. Conclusions: The study revealed that increased tumoral PD-L1 expression may reduce the risk of progression in patients with OSCC. Significance: These findings underscore the potential prognostic significance of PD-L1 expression in OSCC following surgical resection.
        揭示癌症发病的分子机制, 对于改善生存结果至关重要。 本研究探讨程序性死亡配体1 (PD-L1) 表达对口腔鳞状细胞癌 (OSCC) 患者的疾病进展风险的影响。 本研究回顾性纳入了 2012 年 1 月至 2023 年 12 月期间确诊为 OSCC 的成年患者。采用免疫组化方法评估根治性手术切除组织中 PD-L1 的表达, 并计算肿瘤比例评分 (TPS) 和综合阳性评分 (CPS)。进行生存分析以评估其预后意义。 96 例患者中, 52 例(54.2%)的TPS 和65 例(67.7%)的 CPS 达到或超过 20%。 TPS ≥ 20%与黏膜唇部位、疾病分期较早和进展风险降低相关。多变量Cox回归模型显示, III/IV期疾病(HR: 2.176, 95%CI: 1.085-4.376, p = 0.029)和TPS ≥ 20%(HR: 0.241, 95%CI: 0.066-0.879, p = 0.031)是无进展生存期的独立危险因素。 本研究表明, 肿瘤PD-L1表达的增加可能降低口腔鳞状细胞癌(OSCC)患者的疾病进展风险。 这些发现强调了PD-L1表达在口腔鳞状细胞癌手术切除后的潜在预后意义。
      pubtype: Academic Journal
      doctype:
        equations & formulas
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N